Manulife (Manufacturers Life Insurance)
CLVS

Manulife (Manufacturers Life Insurance)’s Clovis Oncology, Inc. CLVS Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-53,000
Closed -$107K – 3232
2022
Q1 		$107K Sell
53,000
-9,982
-16% -$19.6K ﹤0.01% 2951
2021
Q4 		$171 Buy
62,982
+1,262
+2% +$4.67K ﹤0.01% 2950
2021
Q3 		$275K Buy
61,720
+4,335
+8% +$20.9K ﹤0.01% 2743
2021
Q2 		$333K Buy
57,385
+9,262
+19% +$54.3K ﹤0.01% 2740
2021
Q1 		$338K Sell
48,123
-3,612
-7% -$24.2K ﹤0.01% 2539
2020
Q4 		$248K Buy
51,735
+4,420
+9% +$22.4K ﹤0.01% 2633
2020
Q3 		$276K Buy
47,315
+3,917
+9% +$23.4K ﹤0.01% 2350
2020
Q2 		$305K Buy
43,398
+10,242
+31% +$77.5K ﹤0.01% 2244
2020
Q1 		$211K Buy
33,156
+2,136
+7% +$17.1K ﹤0.01% 2297
2019
Q4 		$323K Sell
31,020
-548
-2% -$3.98K ﹤0.01% 2297
2019
Q3 		$126K Buy
31,568
+714
+2% +$5.78K ﹤0.01% 2767
2019
Q2 		$459K Sell
30,854
-307
-1% -$5.55K ﹤0.01% 2104
2019
Q1 		$774K Buy
31,161
+2,127
+7% +$53.3K ﹤0.01% 1834
2018
Q4 		$522K Sell
29,034
-2,000
-6% -$40.9K ﹤0.01% 1932
2018
Q3 		$911K Sell
31,034
-4,168
-12% -$161K ﹤0.01% 1863
2018
Q2 		$1.6M Buy
35,202
+2,584
+8% +$126K ﹤0.01% 1591
2018
Q1 		$1.72M Sell
32,618
-868
-3% -$50.6K ﹤0.01% 1551
2017
Q4 		$2.28M Buy
33,486
+226
+0.7% +$15.8K ﹤0.01% 1440
2017
Q3 		$2.74M Buy
33,260
+2,852
+9% +$226K ﹤0.01% 1344
2017
Q2 		$2.85M Buy
30,408
+4,699
+18% +$288K ﹤0.01% 1354
2017
Q1 		$1.64M Buy
25,709
+3,752
+17% +$228K ﹤0.01% 1501
2016
Q4 		$975K Sell
21,957
-633
-3% -$22.3K ﹤0.01% 1683
2016
Q3 		$815K Sell
22,590
-108
-0.5% -$2.32K ﹤0.01% 1767
2016
Q2 		$311K Buy
22,698
+3,813
+20% +$55.7K ﹤0.01% 2359
2016
Q1 		$364K Buy
18,885
+525
+3% +$11.1K ﹤0.01% 2182
2015
Q4 		$642 Buy
18,360
+171
+0.9% +$11K ﹤0.01% 1865
2015
Q3 		$1.67K Buy
18,189
+2,203
+14% +$191K ﹤0.01% 1415
2015
Q2 		$1.41K Sell
15,986
-472
-3% -$40.4K ﹤0.01% 1518
2015
Q1 		$1.22K Buy
16,458
+535
+3% +$37.8K ﹤0.01% 1568
2014
Q4 		$892 Sell
15,923
-365
-2% -$19.2K ﹤0.01% 1663
2014
Q3 		$738 Buy
16,288
+256
+2% +$10.7K ﹤0.01% 1755
2014
Q2 		$663K Buy
16,032
+2,195
+16% +$113K ﹤0.01% 1846
2014
Q1 		$959 Buy
13,837
+1,220
+10% +$89.6K ﹤0.01% 1657
2013
Q4 		$760 Buy
12,617
+1,341
+12% +$72.9K ﹤0.01% 1777
2013
Q3 		$686 Sell
11,276
-166
-1% -$11.8K ﹤0.01% 1798
2013
Q2 		$767K Buy
+11,442
New +$515K ﹤0.01% 1614

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s CLVS Position: Q2 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Clovis Oncology, Inc. (CLVS) in Q2 2022, closing a stake of 53,000 shares — an estimated $107K sold.

Manulife (Manufacturers Life Insurance) first reported a position in CLVS in Q2 2013 and held it in 36 quarters. The position peaked at $2.85M in Q2 2017. 115 funds tracked by Wall St. Rank hold CLVS as of Q2 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining Clovis Oncology, Inc. position as of Q2 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 53,000 Clovis Oncology, Inc. shares in Q2 2022, an estimated $107K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 36 quarters.
  • Manulife (Manufacturers Life Insurance)'s Clovis Oncology, Inc. position peaked at $2.85M in Q2 2017.
  • 115 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2022, filed 15 Aug 2022.